GSK Says Still In Dark About Nature Of China 'Economic Crimes' Probe
This article was originally published in PharmAsia News
Executive Summary
A weekend after its employees were detained or ousted from three offices in China, GlaxoSmithKline said it still did not know "the precise nature" of investigations of senior managers for "economic crimes."